The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-30. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
=== Phase unknown === AP-002 (AP002) – undefined mechanism of action – opioid-related disorders AP-005 (AP005) – undefined mechanism of action – opioid-related disorders Varenicline implant (SK-2109) – nicotinic acetylcholine receptor agonist – smoking withrawal
From the late 18th century it became apparent that a crystal of a substance was composed of units, whether thought of as atoms, ions, molecules, or polyhedra, in a regular spatial arrangement, termed its crystal structure. The most notable early theory for crystal structures was that of René Just Haüy. In 1801 Haüy, published his Traité de Minéralogie in four volumes, the last of which was an atlas of plates which was considered "among the most wonderful of the 19th century". It has been described as "a work of comprehensive insight, and much of it, written with literary fluency". In this work Haüy described how the law of rational indices establishes relationships between the orientations of the crystal faces, and explains that crystalline solids are formed by replicas of what would now be considered a unit cell. Haüy's theory called for fixed mineral species (based on their molécule intégrante), fixed crystal morphology, and constant chemical composition. This was a mineralogical equivalent to the law of definite proportions in chemistry. John G. Burke (1966) and Hans-Werner Schütt (1984) proposed Haüy's crystal structure theory as an example of a paradigm in the sense of The Structure of Scientific Revolutions by Thomas S. Kuhn (1962). In 1822 Haüy published Traité de Cristallographie an updated version of his work of 1801.
=== 16 January === German Defence Minister Christine Lambrecht resigned in part due to blunders over German support for Ukraine. A grenade exploded in Tonenkoye village's community center, which was used to store ammunition and house Russian soldiers. TASS reported that the RGD-5 grenade explosion in Belgorod Oblast killed 3 soldiers and wounded 16. Eight soldiers were missing. Russia secured control of Soledar after capturing the last industrial zone near mine number 7 from Ukrainian troops. Ukraine admitted that they had lost Soledar.
These outcomes included pain, functional capacity, adverse events, inflammation, disease activity, range of motion, stiffness in the morning, muscle strength, and quality of life. The findings indicate that the differences between utilizing a sham and an infrared laser may be negligible or nonexistent in terms of pain, stiffness in the morning, grip strength, functional ability, inflammation, range of motion, disease activity, and side events. It was also discovered that the data about the effects of laser acupuncture against reflexology in terms of functional ability, quality of life, and inflammation is quite hazy, and about the effects of red laser versus sham in terms of pain, morning stiffness, and side events. The usefulness of red laser, laser acupuncture, and reflexology in the treatment of RA patients is not well enough demonstrated. A 2019 systematic review and meta-analysis found evidence for pain reduction in osteoarthritis. While it does not appear to improve pain in temporomandibular disorders, it may improve function. There is tentative evidence of benefit in tendinopathy. A 2014 review found benefit in shoulder tendinopathy. A 2014 Cochrane review found tentative evidence that it may help in frozen shoulder.
Sources: en.wikipedia.org
=== Sympathetic skin response === Sympathetic skin response (SSR) refers to the change in skin resistance to electrical conduction associated with the sympathetic activation of sudomotor function in response to external or internal stimuli, such as electrical stimulation, deep breathing, and mental stress. It is mediated by a poorly understood somato-sympathetic reflex with spinal, bulbar, and suprabulbar components. The SSR is frequently utilized in psychophysiological studies and is a well-known component of the polygraph test. The test is performed using standard electromyography (EMG) equipment in a lightly dimmed, humidity- and temperature-controlled room. A surface electrode is positioned on the patient's palm or sole, along with a reference electrode on the dorsal side of the same body area. A change in skin potential is then induced either through electrical stimulation or deep breathing. The recorded SSR is then plotted on a graph and analyzed for presence or absence, latency, and amplitude. The SSR is thought to be mainly influenced by the electrolyte content of sweat secreted from eccrine glands. In addition, there is significant intra-individual and inter-individual variability, and SSR declines with age and is commonly absent in individuals over the age of 50. SSR is only considered a surrogate marker of sudomotor function and its results should be interpreted in the context of other sudomotor testing.
== Deficiency == Low values of HbA2, defined as 2.1% and below, can stem from various factors. The different reasons for reduced HbA2 levels depend on the factors such as hematological indices, hemoglobin patterns, red blood cells, and iron status. Reports suggest that individuals with low iron levels often exhibit low levels of HbA2. Additionally, low levels of HbA2 may be caused from decreased transcription or translation of the globin chains, which would affect how they bind.
== Career and research == In 1933 the Ochoas returned to Madrid where he began to study glycolysis in heart muscle. Within two years, he was offered the directorship of the Physiology Section in a newly created Institute for Medical Research at the University of Madrid Medical School. Unfortunately the appointment was made just as the Spanish Civil War erupted. Ochoa decided that trying to perform research in such an environment would destroy forever his "chances of becoming a scientist." Thus, "after much thought, my wife and I decided to leave Spain." In September 1936 they began what he later called the "wander years" as they traveled from Spain to Germany, to England, and ultimately to the United States within a span of four years. Ochoa left Spain and returned to Meyerhof's Kaiser Wilhelm Institute for Biology now relocated in Heidelberg, where Ochoa found a profoundly changed research focus. During his 1930 visit the laboratory work was "classical physiology," which Ochoa described as "one could see muscles twitching everywhere". By 1936 Meyerhof's laboratory had become one of the world's foremost biochemical facilities focused on processes such as glycolysis and fermentation. Rather than studying muscles "twitch," the lab was now purifying and characterizing the enzymes involved in muscle action and those involved in yeast fermentation.
Sources: en.wikipedia.org
== Recent recognition == 2019 - Honorary Doctor of Science Degree, Clarkson University 2019 - Herman S. Bloch Award for Scientific Excellence in Industry, University of Chicago 2011 - American Association for Cancer Research Award for Excellence in Chemistry in Cancer Research 2007 - Nobel Laureate Signature Award for Graduate Education in Chemistry, with Anirban Banerjee 2005 - Royal Society of Chemistry Nucleic Acid Award Lecture, Responses to DNA Damage conference
The many-worlds interpretation is discussed by high-level avout at evening meals to which Erasmas performs the duties of a servant. It is hinted that Laterre is a futuristic Earth, which serves as a 'higher plane of existence' for Urnud and Tro, and Arbre is itself a 'higher plane' for Laterre and Fthos. Through observation and experiment, Erasmas and his companions determine that the conference has been infiltrated by the aliens and unmask a French-speaking Laterran linguist named Jules Verne Durand. He explains that the aliens are experiencing internal conflict between two factions. The currently ruling faction (the more militaristic 'lower worlds' Urnud and Tro, as well as some Laterrans) intends to attack and raid Arbre for its resources in order to repair their spaceship, while the opposing faction ('the higher world' Fthos and most Laterrans) favors open negotiation. Durand believes that an alliance could be formed between Arbre and the peaceful faction and offers to help the Arbrans. Fearing alien attack after Durand has been exposed, the avout simultaneously evacuate all concents including Saunt Tredegarh. Erasmas and his comrades are taken to a distant sanctuary where they undergo astronaut training for a mission to board the alien ship, disable its weaponry and negotiate with the aliens. Prior to launch and without their knowledge, the Sæcular Power implants each of them with miniaturized neutron bombs that will be used to kill everyone aboard the alien ship if the mission fails. Three people, including Fraa Jad, are issued detonators.
Nutty Professor II: The Klumps at IMDb Nutty Professor II: The Klumps at the TCM Movie Database (archived) Nutty Professor II: The Klumps at the AFI Catalog of Feature Films Nutty Professor II: The Klumps at Box Office Mojo Nutty Professor II: The Klumps at Rotten Tomatoes Nutty Professor II: The Klumps at Metacritic
4 Li + 2 SOCl2 → 4 LiCl + 1⁄8 S8 + SO2 These non-rechargeable batteries have advantages over other forms of lithium batteries such as a high energy density, a wide operational temperature range, and long storage and operational lifespans. They are popular power sources for IoT devices such as asset trackers and utility meters as well as military and aircraft emergency beacons. However, their high cost, non-rechargeability, and safety concerns have limited their use in consumer devices. The contents of the batteries are very corrosive, the SO2 is toxic by inhalation, and the batteries therefore require special disposal procedures; additionally, they may explode if shorted. The technology was used on the 1997 Sojourner Mars rover.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.